mentholatum (overseas) limited
mentholatum (overseas) limited Company Information
Company Number
00861119
Next Accounts
Nov 2025
Shareholders
mentholatum co ltd
Group Structure
View All
Industry
Activities of other holding companies (not including agricultural, production, construction, distribution and financial services holding companies) n.e.c.
Registered Address
suite 5, 7th floor 50 broadway, london, SW1H 0DB
mentholatum (overseas) limited Estimated Valuation
Pomanda estimates the enterprise value of MENTHOLATUM (OVERSEAS) LIMITED at £0 based on a Turnover of £0 and 1.05x industry multiple (adjusted for size and gross margin).
mentholatum (overseas) limited Estimated Valuation
Pomanda estimates the enterprise value of MENTHOLATUM (OVERSEAS) LIMITED at £0 based on an EBITDA of £0 and a 4.38x industry multiple (adjusted for size and gross margin).
mentholatum (overseas) limited Estimated Valuation
Pomanda estimates the enterprise value of MENTHOLATUM (OVERSEAS) LIMITED at £0 based on Net Assets of £-58.2k and 1.31x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Mentholatum (overseas) Limited Overview
Mentholatum (overseas) Limited is a live company located in london, SW1H 0DB with a Companies House number of 00861119. It operates in the activities of other holding companies n.e.c. sector, SIC Code 64209. Founded in October 1965, it's largest shareholder is mentholatum co ltd with a 100% stake. Mentholatum (overseas) Limited is a mature, unknown sized company, Pomanda has estimated its turnover at £0 with unknown growth in recent years.
Upgrade for unlimited company reports & a free credit check
Mentholatum (overseas) Limited Health Check
There is insufficient data available to calculate a health check for Mentholatum (Overseas) Limited. Company Health Check FAQs
0 Strong
0 Regular
1 Weak
Size
There is insufficient data available for this Key Performance Indicator!
- - Mentholatum (overseas) Limited
- - Industry AVG
Growth
There is insufficient data available for this Key Performance Indicator!
- Mentholatum (overseas) Limited
- - Industry AVG
Production
There is insufficient data available for this Key Performance Indicator!
- - Mentholatum (overseas) Limited
- - Industry AVG
Profitability
There is insufficient data available for this Key Performance Indicator!
- - Mentholatum (overseas) Limited
- - Industry AVG
Employees
with 1 employees, this is below the industry average (103)
- Mentholatum (overseas) Limited
- - Industry AVG
Pay Structure
There is insufficient data available for this Key Performance Indicator!
- Mentholatum (overseas) Limited
- - Industry AVG
Efficiency
There is insufficient data available for this Key Performance Indicator!
- Mentholatum (overseas) Limited
- - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- - Mentholatum (overseas) Limited
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- - Mentholatum (overseas) Limited
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Mentholatum (overseas) Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Mentholatum (overseas) Limited
- - Industry AVG
Debt Level
There is insufficient data available for this Key Performance Indicator!
- - Mentholatum (overseas) Limited
- - Industry AVG
MENTHOLATUM (OVERSEAS) LIMITED financials
Mentholatum (Overseas) Limited's latest turnover from February 2024 is 0 and the company has net assets of -£58.2 thousand. According to their latest financial statements, we estimate that Mentholatum (Overseas) Limited has 1 employee and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Feb 2024 | Feb 2023 | Feb 2022 | Feb 2021 | Feb 2020 | Feb 2019 | Feb 2018 | Feb 2017 | Feb 2016 | Feb 2015 | Feb 2014 | Feb 2013 | Feb 2012 | Feb 2011 | Feb 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | |||||||||||||||
| Other Income Or Grants | |||||||||||||||
| Cost Of Sales | |||||||||||||||
| Gross Profit | |||||||||||||||
| Admin Expenses | |||||||||||||||
| Operating Profit | |||||||||||||||
| Interest Payable | |||||||||||||||
| Interest Receivable | |||||||||||||||
| Pre-Tax Profit | |||||||||||||||
| Tax | |||||||||||||||
| Profit After Tax | |||||||||||||||
| Dividends Paid | |||||||||||||||
| Retained Profit | |||||||||||||||
| Employee Costs | |||||||||||||||
| Number Of Employees | |||||||||||||||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Feb 2024 | Feb 2023 | Feb 2022 | Feb 2021 | Feb 2020 | Feb 2019 | Feb 2018 | Feb 2017 | Feb 2016 | Feb 2015 | Feb 2014 | Feb 2013 | Feb 2012 | Feb 2011 | Feb 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | |||||||||||||||
| Intangible Assets | |||||||||||||||
| Investments & Other | |||||||||||||||
| Debtors (Due After 1 year) | |||||||||||||||
| Total Fixed Assets | |||||||||||||||
| Stock & work in progress | |||||||||||||||
| Trade Debtors | |||||||||||||||
| Group Debtors | |||||||||||||||
| Misc Debtors | |||||||||||||||
| Cash | |||||||||||||||
| misc current assets | |||||||||||||||
| total current assets | |||||||||||||||
| total assets | |||||||||||||||
| Bank overdraft | |||||||||||||||
| Bank loan | |||||||||||||||
| Trade Creditors | |||||||||||||||
| Group/Directors Accounts | 58,206 | 58,206 | 58,206 | 58,206 | 58,206 | 58,206 | 58,206 | 58,206 | 58,206 | 58,206 | 58,206 | 58,206 | 58,206 | ||
| other short term finances | |||||||||||||||
| hp & lease commitments | |||||||||||||||
| other current liabilities | |||||||||||||||
| total current liabilities | 58,206 | 58,206 | 58,206 | 58,206 | 58,206 | 58,206 | 58,206 | 58,206 | 58,206 | 58,206 | 58,206 | 58,206 | 58,206 | ||
| loans | |||||||||||||||
| hp & lease commitments | |||||||||||||||
| Accruals and Deferred Income | |||||||||||||||
| other liabilities | |||||||||||||||
| provisions | |||||||||||||||
| total long term liabilities | |||||||||||||||
| total liabilities | 58,206 | 58,206 | 58,206 | 58,206 | 58,206 | 58,206 | 58,206 | 58,206 | 58,206 | 58,206 | 58,206 | 58,206 | 58,206 | ||
| net assets | -58,206 | -58,206 | -58,206 | -58,206 | -58,206 | -58,206 | -58,206 | -58,206 | -58,206 | -58,206 | -58,206 | -58,206 | -58,206 | ||
| total shareholders funds | -58,206 | -58,206 | -58,206 | -58,206 | -58,206 | -58,206 | -58,206 | -58,206 | -58,206 | -58,206 | -58,206 | -58,206 | -58,206 |
| Feb 2024 | Feb 2023 | Feb 2022 | Feb 2021 | Feb 2020 | Feb 2019 | Feb 2018 | Feb 2017 | Feb 2016 | Feb 2015 | Feb 2014 | Feb 2013 | Feb 2012 | Feb 2011 | Feb 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||
| Operating Profit | |||||||||||||||
| Depreciation | |||||||||||||||
| Amortisation | |||||||||||||||
| Tax | |||||||||||||||
| Stock | |||||||||||||||
| Debtors | |||||||||||||||
| Creditors | |||||||||||||||
| Accruals and Deferred Income | |||||||||||||||
| Deferred Taxes & Provisions | |||||||||||||||
| Cash flow from operations | |||||||||||||||
| Investing Activities | |||||||||||||||
| capital expenditure | |||||||||||||||
| Change in Investments | |||||||||||||||
| cash flow from investments | |||||||||||||||
| Financing Activities | |||||||||||||||
| Bank loans | |||||||||||||||
| Group/Directors Accounts | 58,206 | -58,206 | 58,206 | ||||||||||||
| Other Short Term Loans | |||||||||||||||
| Long term loans | |||||||||||||||
| Hire Purchase and Lease Commitments | |||||||||||||||
| other long term liabilities | |||||||||||||||
| share issue | |||||||||||||||
| interest | |||||||||||||||
| cash flow from financing | |||||||||||||||
| cash and cash equivalents | |||||||||||||||
| cash | |||||||||||||||
| overdraft | |||||||||||||||
| change in cash |
mentholatum (overseas) limited Credit Report and Business Information
Mentholatum (overseas) Limited Competitor Analysis
Perform a competitor analysis for mentholatum (overseas) limited by selecting its closest rivals, whether from the FINANCIAL AND INSURANCE ACTIVITIES sector, other mature companies, companies in SW1H area or any other competitors across 12 key performance metrics.
mentholatum (overseas) limited Ownership
MENTHOLATUM (OVERSEAS) LIMITED group structure
Mentholatum (Overseas) Limited has no subsidiary companies.
Ultimate parent company
ROHTO PHARMACEUTICAL CO LTD
#0006596
2 parents
MENTHOLATUM (OVERSEAS) LIMITED
00861119
mentholatum (overseas) limited directors
Mentholatum (Overseas) Limited currently has 3 directors. The longest serving directors include Ms Linda McColgan (Sep 2018) and Mr Michael Izon (Aug 2021).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Ms Linda McColgan | Scotland | 52 years | Sep 2018 | - | Director |
| Mr Michael Izon | Scotland | 56 years | Aug 2021 | - | Director |
| Mr Andrew Lawlor | Scotland | 44 years | Sep 2024 | - | Director |
P&L
February 2024turnover
0
0%
operating profit
0
0%
gross margin
0%
0%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
February 2024net assets
-58.2k
0%
total assets
0
0%
cash
0
0%
net assets
Total assets minus all liabilities
Similar Companies
mentholatum (overseas) limited company details
company number
00861119
Type
Private limited with Share Capital
industry
64209 - Activities of other holding companies (not including agricultural, production, construction, distribution and financial services holding companies) n.e.c.
incorporation date
October 1965
age
60
incorporated
UK
ultimate parent company
accounts
Dormant
last accounts submitted
February 2024
previous names
N/A
accountant
-
auditor
-
address
suite 5, 7th floor 50 broadway, london, SW1H 0DB
Bank
BARCLAYS BANK PLC
Legal Advisor
-
mentholatum (overseas) limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to mentholatum (overseas) limited.
mentholatum (overseas) limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for MENTHOLATUM (OVERSEAS) LIMITED. This can take several minutes, an email will notify you when this has completed.
mentholatum (overseas) limited Companies House Filings - See Documents
| date | description | view/download |
|---|
